The fda was really generous with their time an talking to us about this stuff, because they stand by it. The important part about a fordability and availability of tests isn't the number of tests on the market. It's actually federal government commitment to purchasing large volumes of tests. And so they would send you to the back of the line. Tit's called being d prioritized. This happened to companies big and small, and it cost a lot of frustration.
And why they're easy to find in Europe (though they don't seem to be helping much at the moment).
Today’s show was produced by Miles Bryan with help from Will Reid, edited by Matt Collette, engineered by Efim Shapiro, fact-checked by Laura Bullard and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices